Pseudocyst

Global Pancreatic Fistula Treatment Market Report 2022-2028: A $2+ Billion Market in 2021 - Higher Adoption of Surgical Techniques to Drive Market Growth - ResearchAndMarkets.com

Retrieved on: 
Tuesday, December 20, 2022
Surgery, Health, Adenocarcinoma, Medtronic, Somatostatin, Federation, Administration, Parenteral nutrition, Pancreatic fistula, ERCP, Cannula, Food, Vitamin, Pancreatic neuroendocrine tumor, US, Acquisition, Growth, Carbohydrate, Novartis, Fistula, Trauma, Unitary state, Mineral, Maximal and minimal elements, Pancreatic cancer, Pseudocyst, Prevalence, Biopsy, Pet, Medical imaging, Pharmaceutical industry, Marketing, Others

In 2021, surgical devices segment dominated the market owing to comparatively higher adoption of medical devices to diagnose and treat pancreatic fistula.

Key Points: 
  • In 2021, surgical devices segment dominated the market owing to comparatively higher adoption of medical devices to diagnose and treat pancreatic fistula.
  • Market is studied in order to understand the current and future market trends in the pancreatic fistula treatment market.
  • What are the key micro and macro environmental factors that are impacting the growth of Pancreatic Fistula Treatment market?
  • Who are the key competitors and what are their key strategies to enhance their market presence in the Pancreatic Fistula Treatment market worldwide?

RWJBarnabas Health Pioneers Innovative Pancreatic Cyst Surveillance Program

Retrieved on: 
Thursday, March 11, 2021
Cysts, Pancreas disorders, Health, Medicine, Anatomy, Gross pathology, Pancreatic cyst, Pancreatic cancer, Rare diseases, Pseudocyst, Pancreatic pseudocyst

Through its unique partnership with Eon, a healthcare technology company, SBMC's Pancreatic Cyst Surveillance Program identifies patients when incidental scans, such as a magnetic resonance imaging (MRI), computerized tomography scan (CT) or ultrasound, detect pancreatic cysts, and at-risk people are then contacted through a nurse navigator for potential follow-up.

Key Points: 
  • Through its unique partnership with Eon, a healthcare technology company, SBMC's Pancreatic Cyst Surveillance Program identifies patients when incidental scans, such as a magnetic resonance imaging (MRI), computerized tomography scan (CT) or ultrasound, detect pancreatic cysts, and at-risk people are then contacted through a nurse navigator for potential follow-up.
  • Once a patient elects to enroll in the program, a nurse navigator will assist with scheduling the necessary screening, procedures or surgery.
  • "Because pancreatic surgery carries morbidity and a potential mortality rate, we want to ensure patients aren't undergoing unnecessary surgery, however when a pancreatic cyst does require surgery, we want to operate at the most opportune time."
  • Approximately 15 percent of Americans are believed to have a pancreatic cyst, and unlike other cysts such as those on the ovaries, liver or kidneys, pancreatic cysts carry the potential to increase the patient's risk for pancreatic cancer.